PRESTIGE CONSUMER HEALTHCARE INC. Goodwill, Acquired During Period
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Goodwill, Acquired During Period of $65.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for the quarter ending 2026-06-30 was $65.50M.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for the quarter ending 2026-03-31 was $133.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for the quarter ending 2025-03-31 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for the quarter ending 2024-12-31 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for fiscal 2026 was $52.77M, a 16978.32% increase from fiscal 2025.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for fiscal 2025 was $309.00K, a 48.50% decline from fiscal 2024.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for fiscal 2024 was $600.00K.
- PRESTIGE CONSUMER HEALTHCARE INC. goodwill, acquired during period for fiscal 2022 was $1.65M.
| Period end | Goodwill, Acquired During Period | Goodwill, Acquired During Period as first filed | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $65.50M 10-Q · filed 2026-08-06 | $65.64M derived: sum of 2 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | $52.77M 10-K · filed 2026-05-14 | |||||
| 2025-12-31 | $52.64M 10-Q · filed 2026-02-05 | ||||||
| 2025-12-18 | $52.80M 10-K · filed 2026-05-14 | $52.60M 10-Q · filed 2026-02-05 | |||||
| 2025-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-05-09 | $0.00 derived: sum of 3 quarters · filed 2025-05-09 | $309.00K 10-K · filed 2025-05-09 | |||
| 2024-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06 | $0.00 derived: sum of 2 quarters · filed 2025-02-06 | $309.00K 10-Q · filed 2025-02-06 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $309.00K 10-Q · filed 2024-11-07 | |||||
| 2024-06-30 | $309.00K 10-Q · filed 2024-08-08 | ||||||
| 2024-03-31 | $600.00K 10-K · filed 2026-05-14 | $621.00K 10-K · filed 2024-05-15 | |||||
| 2024-01-08 | $600.00K 10-K · filed 2024-05-15 | ||||||
| 2022-03-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-05 | -$110.00K derived: sum of 2 quarters · filed 2023-05-05 | $1.65M 10-K · filed 2023-05-05 | ||||
| 2021-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | $1.76M 10-Q · filed 2022-02-03 | |||||
| 2021-09-30 | $1.76M 10-Q · filed 2021-11-04 | ||||||
| 2019-03-31 | $0.00 10-K · filed 2019-05-13 | ||||||
| 2017-03-31 | $268.58M 10-K · filed 2018-05-10 | ||||||
| 2016-03-31 | $76.83M 10-K · filed 2017-05-17 | ||||||
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-17 | $0.00 derived: sum of 2 quarters · filed 2017-05-17 | $103.25M derived: sum of 3 quarters · filed 2017-05-17 | $104.48M 10-K · filed 2017-05-17 | |||
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $103.25M derived: sum of 2 quarters · filed 2015-02-05 | $104.48M 10-Q · filed 2015-02-05 | $104.48M derived: sum of 4 quarters · filed 2016-05-17 | |||
| 2014-09-30 | $103.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-06 | $104.48M 10-Q · filed 2014-11-06 | $104.48M derived: sum of 3 quarters · filed 2016-05-17 | $104.48M derived: sum of 4 quarters · filed 2016-05-17 | |||
| 2014-06-30 | $1.22M 10-Q · filed 2014-08-07 | $1.22M derived: sum of 2 quarters · filed 2016-05-17 | $1.22M derived: sum of 3 quarters · filed 2016-05-17 | ||||
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-05-17 | $0.00 derived: sum of 2 quarters · filed 2016-05-17 | $23.12M 10-K · filed 2016-05-17 | ||||
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-07 | $23.12M 10-Q · filed 2014-02-07 | |||||
| 2013-09-30 | $23.12M 10-Q · filed 2013-11-07 | ||||||
| 2013-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14 | $0.00 derived: sum of 2 quarters · filed 2015-05-14 | $0.00 derived: sum of 3 quarters · filed 2015-05-14 | $226.00K 10-K · filed 2015-05-14 | |||
| 2012-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-07 | $0.00 derived: sum of 2 quarters · filed 2013-02-07 | $226.00K 10-Q · filed 2013-02-07 | ||||
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $226.00K 10-Q · filed 2012-11-07 | |||||
| 2012-06-30 | $226.00K 10-Q · filed 2012-08-09 | ||||||
| 2012-03-31 | $20.01M 10-K · filed 2014-05-19 | ||||||
| 2011-03-31 | $43.41M 10-K · filed 2013-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |